Education
About Us
Working with TipRanks
Follow Us
Surgery Partners Inc (SGRY)
NASDAQ:SGRY
SGRY Stock Chart & Stats
$11.80
$0.26(1.26%)
At close: 4:00 PM EST
$11.80
$0.26(1.26%)
Day’s Range― - ―
52-Week Range$11.61 - $24.60
Previous CloseN/A
Volume149.01K
Average Volume (3M)2.03M
Market Cap
$1.53B
Enterprise Value$5.34B
Total Cash (Recent Filing)$239.90M
Total Debt (Recent Filing)$4.02B
Price to Earnings (P/E)―
Beta1.22
Next Earnings
May 05, 2026EPS Estimate
-0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.12
Shares Outstanding129,419,830
10 Day Avg. Volume1,767,659
30 Day Avg. Volume2,029,457
Financial Highlights & Ratios
PEG Ratio0.47
Price to Book (P/B)1.15
Price to Sales (P/S)0.59
P/FCF Ratio10.05
Enterprise Value/Market Cap3.49
Enterprise Value/Revenue1.61
Enterprise Value/Gross Profit6.97
Enterprise Value/Ebitda5.61
Forecast
1Y Price Target
$20.31Price Target Upside72.12% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
EPS Forecast (FY)0.42
Revenue Forecast (FY)$3.41B
Bulls Say, Bears Say
Bulls Say
Activist Campaign And GovernanceActivist hedge fund push for board refresh and a new management team raises the prospect of decisive governance changes that could unlock shareholder value, given the activist's prior successful healthcare proxy initiatives.
Divestiture Proceeds And Capital AllocationSale of the surgical hospitals could generate substantial cash to fund share repurchases, pay down debt, and improve the company's credit profile, aligning capital allocation with value creation goals.
Operational Cost InitiativesStandardizing purchasing, rethinking operating room staffing, and increasing use of nurse anesthetists are targeted measures that could lower operating expenses as remediation and leadership changes progress.
Bears Say
Leverage And Credit RiskHigh leverage may constrain strategic flexibility and creditworthiness, making debt reduction a critical requirement before pursuing larger strategic initiatives.
Market-specific UnderperformanceUnderperformance at several surgical hospital markets has already driven missed adjusted profitability expectations, highlighting concentrated operational risks that could pressure future earnings.
Payer Mix And Physician StaffingA shift toward Medicare payers alongside physician retirements and slower ramp-up of new recruits can reduce procedure volumes and worsen the revenue mix, prompting conservative guidance and ongoing cost headwinds.
Surgery Partners News
SGRY FAQ
What was Surgery Partners Inc’s price range in the past 12 months?
Surgery Partners Inc lowest stock price was $11.61 and its highest was $24.60 in the past 12 months.
What is Surgery Partners Inc’s market cap?
Surgery Partners Inc’s market cap is $1.53B.
When is Surgery Partners Inc’s upcoming earnings report date?
Surgery Partners Inc’s upcoming earnings report date is May 05, 2026 which is in 42 days.
How were Surgery Partners Inc’s earnings last quarter?
Surgery Partners Inc released its earnings results on Mar 02, 2026. The company reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.304 by -$0.184.
Is Surgery Partners Inc overvalued?
According to Wall Street analysts Surgery Partners Inc’s price is currently Undervalued.
Does Surgery Partners Inc pay dividends?
Surgery Partners Inc does not currently pay dividends.
What is Surgery Partners Inc’s EPS estimate?
Surgery Partners Inc’s EPS estimate is -0.12.
How many shares outstanding does Surgery Partners Inc have?
Surgery Partners Inc has 129,419,830 shares outstanding.
What happened to Surgery Partners Inc’s price movement after its last earnings report?
Surgery Partners Inc reported an EPS of $0.12 in its last earnings report, missing expectations of $0.304. Following the earnings report the stock price went down -12.343%.
Which hedge fund is a major shareholder of Surgery Partners Inc?
Currently, no hedge funds are holding shares in SGRY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Surgery Partners Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$20.31 (72.12% Upside)
$20.31 (72.12% Upside)
Blogger Sentiment
Bullish
SGRY Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 520.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 0.7%
Last 30 Days ▲ 7.5%
Last 30 Days ▲ 7.5%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-51.61%
12-Months-Change
Fundamentals
Return on Equity
-4.50%
Trailing 12-Months
Asset Growth
2.91%
Trailing 12-Months
Company Description
Surgery Partners Inc
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
SGRY Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call conveyed a mixed view: solid top-line growth (net revenue +6.2%, same-facility revenue +4.9%) and progress on strategic initiatives (orthopedic growth, robotics, physician recruitment, portfolio optimization), but material near-term operational challenges concentrated in three surgical hospital markets led to an earnings shortfall, margin compression (-40 bps), payer mix headwinds, and costs that outpaced revenue in those locales. Management emphasized these issues are identifiable and addressable and provided conservative 2026 guidance that incorporates the headwinds.View all SGRY earnings summariesSGRY Stock 12 Month Forecast
Average Price Target
$20.31
▲(72.12% Upside)
Technical Analysis
HCA Healthcare
―
Encompass Health
―
National Healthcare
―
Tenet Healthcare
―
Universal Health
―
Ownership Overview
Currently, No data available
---